Please use this identifier to cite or link to this item:
|Title:||Tumor and microenvironment modification during progression of murine orthotopic bladder cancer||Authors:||Tham, S.M.
|Issue Date:||2011||Citation:||Tham, S.M., Ng, K.H., Pook, S.H., Esuvaranathan, K., Mahendran, R. (2011). Tumor and microenvironment modification during progression of murine orthotopic bladder cancer. Clinical and Developmental Immunology 2011 : -. ScholarBank@NUS Repository. https://doi.org/10.1155/2011/865684||Abstract:||The aim of this study was to monitor changes in the expression of immune-related genes in the bladder after tumor implantation. Mice were orthotopically implanted with MB49-PSA cells (C57BL/6 mice) on day 1 and terminated on days 7, 14, 21, and 28. Another mouse model (MBT-2/C3H mice) was examined at day 7. Gene expression analysis was performed using a TaqMan Low Density Mouse Immune Panel (Applied Biosystems, USA) on RNA extracted from the bladders. Selected genes were reconfirmed by real-time PCR analysis and RT-PCR on the mRNA from other animals. Immune suppressive (IL13, IL1, PTGS2, NOS2, IL10, CTLA4, and CCL22) and immune stimulatory genes (CSF2, GZMB, IFN, CXCL10, TNF, CD80, IL12a, and IL6) and AGTR2 were increased by day 7. By day 28, IL10, CCL2, CCL5, CXCL11, CTLA4, GZMB, IFN, CSF2, and IL6 were significantly increased. Therapeutic strategies involving TH1 induction and TH2 dampening may improve responses to immunotherapy. Copyright © 2011 Sin Mun Tham et al.||Source Title:||Clinical and Developmental Immunology||URI:||http://scholarbank.nus.edu.sg/handle/10635/109720||ISSN:||17402522||DOI:||10.1155/2011/865684|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|2011-Tumor_microenvironment_modification_during_progression-published.pdf||1.17 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.